5-1232751-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_182632.3(SLC6A18):āc.302G>Cā(p.Gly101Ala) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000067 in 1,612,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_182632.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A18 | NM_182632.3 | c.302G>C | p.Gly101Ala | missense_variant, splice_region_variant | 3/12 | ENST00000324642.4 | NP_872438.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A18 | ENST00000324642.4 | c.302G>C | p.Gly101Ala | missense_variant, splice_region_variant | 3/12 | 1 | NM_182632.3 | ENSP00000323549.3 | ||
SLC6A18 | ENST00000513607.2 | n.371G>C | splice_region_variant, non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000108 AC: 27AN: 249452Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 134870
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1459938Hom.: 0 Cov.: 31 AF XY: 0.0000840 AC XY: 61AN XY: 726144
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152160Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.302G>C (p.G101A) alteration is located in exon 3 (coding exon 3) of the SLC6A18 gene. This alteration results from a G to C substitution at nucleotide position 302, causing the glycine (G) at amino acid position 101 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at